Latest Breaking News On - Iopharmaceutical company entrada - Page 1 : comparemela.com

Biopharmaceutical company Entrada Therapeutics, Inc. (TRDA) announced Wednesday the completion of dosing for the first and second cohorts of its Phase 1 clinical trial, ENTR-601-44-101.

Entrada therapeutics incEntrada therapeuticsIopharmaceutical company entrada